Evidence map›Paper›PMID 28818792›Full record

ArticleRedox biology2017

Regulation of type I interferon responses by mitochondria-derived reactive oxygen species in plasmacytoid dendritic cells.

Zsofia Agod, Tünde Fekete, Marietta M Budai, Aliz Varga, Attila Szabo, Hyelim Moon, Istvan Boldogh, Tamas Biro, Arpad Lanyi, Attila Bacsi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Inhibition of LDHA promotes GSDME-dependent pyroptosis by activating RIG-I-like receptor signaling.Apoptosis : an international journal on programmed cell death · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Curcumin protects against MPPMolecular biology reports · 2025
    Article
  10. IFN-α Induces Heterogenous ROS Production in Human β-Cells.bioRxiv : the preprint server for biology · 2025
    Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Zsofia AgodDepartment of Immunology, Faculty of Medicine, University of Debrecen, 1 Egyetem Square, Debrecen H-4032, Hungary.
Tünde FeketeDepartment of Immunology, Faculty of Medicine, University of Debrecen, 1 Egyetem Square, Debrecen H-4032, Hungary.
Marietta M BudaiDepartment of Immunology, Faculty of Medicine, University of Debrecen, 1 Egyetem Square, Debrecen H-4032, Hungary.
Aliz VargaDepartment of Immunology, Faculty of Medicine, University of Debrecen, 1 Egyetem Square, Debrecen H-4032, Hungary.
Attila SzaboDepartment of Immunology, Faculty of Medicine, University of Debrecen, 1 Egyetem Square, Debrecen H-4032, Hungary; Department of Bioengineering, Sapientia Hungarian University of Transylvania, Cluj-Napoca 400112, Romania.
Hyelim MoonDepartment of Immunology, Faculty of Medicine, University of Debrecen, 1 Egyetem Square, Debrecen H-4032, Hungary.
Istvan BoldoghDepartment of Microbiology and Immunology, University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX 77555, USA.
Tamas BiroDepartment of Immunology, Faculty of Medicine, University of Debrecen, 1 Egyetem Square, Debrecen H-4032, Hungary.
Arpad LanyiDepartment of Immunology, Faculty of Medicine, University of Debrecen, 1 Egyetem Square, Debrecen H-4032, Hungary; Department of Bioengineering, Sapientia Hungarian University of Transylvania, Cluj-Napoca 400112, Romania.
Attila BacsiDepartment of Immunology, Faculty of Medicine, University of Debrecen, 1 Egyetem Square, Debrecen H-4032, Hungary; Department of Bioengineering, Sapientia Hungarian University of Transylvania, Cluj-Napoca 400112, Romania.
Kitti PazmandiDepartment of Immunology, Faculty of Medicine, University of Debrecen, 1 Egyetem Square, Debrecen H-4032, Hungary. Electronic address: pazmandikitti@yahoo.de.
University of Debrecen · HUSapientia Hungarian University of Transylvania · ROThe University of Texas Medical Branch at Galveston · US

Funding

Virus, Tissue Culture and ImmunoassayP01AI062885 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI CASOLA, ANTONELLA · 2005 to 2022
$23.9M
NIAID NIH HHS P01 AI062885
6 · The paper itself

Abstract

Mitochondrial reactive oxygen species (mtROS) generated continuously under physiological conditions have recently emerged as critical players in the regulation of immune signaling pathways. In this study we have investigated the regulation of antiviral signaling by increased mtROS production in plasmacytoid dendritic cells (pDCs), which, as major producers of type I interferons (IFN), are the key coordinators of antiviral immunity. The early phase of type I IFN production in pDCs is mediated by endosomal Toll-like receptors (TLRs), whereas the late phase of IFN response can also be triggered by cytosolic retinoic acid-inducible gene-I (RIG-I), expression of which is induced upon TLR stimulation. Therefore, pDCs provide an ideal model to study the impact of elevated mtROS on the antiviral signaling pathways initiated by receptors with distinct subcellular localization. We found that elevated level of mtROS alone did not change the phenotype and the baseline cytokine profile of resting pDCs. Nevertheless increased mtROS levels in pDCs lowered the TLR9-induced secretion of pro-inflammatory mediators slightly, whereas reduced type I IFN production markedly via blocking phosphorylation of interferon regulatory factor 7 (IRF7), the key transcription factor of the TLR9 signaling pathway. The TLR9-induced expression of RIG-I in pDCs was also negatively regulated by enhanced mtROS production. On the contrary, elevated mtROS significantly augmented the RIG-I-stimulated expression of type I IFNs, as well as the expression of mitochondrial antiviral-signaling (MAVS) protein and the phosphorylation of Akt and IRF3 that are essential components of RIG-I signaling. Collectively, our data suggest that increased mtROS exert diverse immunoregulatory functions in pDCs both in the early and late phase of type I IFN responses depending on which type of viral sensing pathway is stimulated.

Indexed as

Cell LineCells, CulturedDEAD Box Protein 58Dendritic CellsHumansInterferon Regulatory Factor-7Interferon Type IMitochondriaReactive Oxygen SpeciesReceptors, ImmunologicSignal TransductionToll-Like Receptor 9DEAD Box Protein 58Interferon Regulatory Factor-7Interferon Type IIRF7 protein, humanReactive Oxygen SpeciesReceptors, ImmunologicRIGI protein, humanTLR9 protein, humanToll-Like Receptor 9Antiviral responseEndosomal TLR signalingMitochondrial ROSPlasmacytoid dendritic cellRIG-I signalingType I interferon

Identifiers

PMID28818792
PMCPMC5558471
OpenAlexW2741486236

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.